stathmin and breast cancer resistance to antimicrotubule agents
| PAG Title | stathmin and breast cancer resistance to antimicrotubule agents |
| PAG ID | WAG001038 |
| Type | P |
| Source Link |  BioCarta |
| Publication Reference | NA |
| PAG Description | Stathmin is a ubiquitous, cytosolic 19-kDa protein, which is phosphorylated on up to four sites in response to many regulatory sigls within cells. Its molecular characterization indicates a functiol organization including an N-termil regulatory domain that bears the phosphorylation sites, linked to a putative alpha-helical binding domain predicted to participate in coiled-coil, protein-protein interactions. In addtion to the protein kises that phospjhorylate Stathmin such as CaMK, MAPK, p34cdc2, PKA, a few other proteins have been suggested to interact with stathmin in vivo. One of them was identified as BiP, a member of the hsp70 heat-shock protein family. Another is a previously unidentified, putative serine/threonine kise, KIS, which might be regulated by stathmin or, more likely, be part of the kises controlling its phosphorylation state. Filly, two proteins, CC1 and CC2, predicted to form alpha-helices participating in coiled-coil interacting structures. It has been also suggest that the action of antimicrotubule drugs can be affected by stathmin in at least two ways: (a) altered drug binding; and (b) growth arrest at the G2 to M boundary. Mutant p53 breast cancers exhibiting high levels of stathmin may be resistant to antimicrotubule agents. |
| Species | Homo sapiens |
| Quality Metric Scores | nCoCo Score: 1,461 |
| Information Content | Rich |
| Other IDs | |
| Base PAG ID | WAG001038 |
| Human Phenotyte Annotation | |
| Curator | PAGER curation team |
| Curator Contact | PAGER-contact@googlegroups.com |
">
Something else? Please send us an email!